Nuwellis Sets 1-for-9 Reverse Stock Split Effective October 27; Shares Fall 12.5%

Nuwellis, Inc. (NUWE) will implement a 1-for-9 reverse split of its common stock, effective Tuesday, October 27, 2026, the medical device maker said Friday. Shares were trading at $4.70, down 12.48%. The CUSIP number for the company's common stock will change to 67113Y884 in conjunction with the split. Nuwellis' Aquadex FlexFlow and Aquadex SmartFlow systems are used to treat fluid overload in heart failure patients. For the second quarter of 2026, the company reported revenue of approximately $2.0 million, up 14% from approximately $1.7 million a year earlier. Net loss was approximately $4.8 million, including approximately $1.7 million in non-cash warrant valuation expense tied to its June 2026 financing, compared with a net loss of $12.6 million in the prior-year quarter. NUWE has traded between $2.52 and $1,556 over the past 52 weeks.